ALXO vs REGN: Which Stock is Better?

Side-by-side comparison of Alx Oncology Holdings Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ALXO

Alx Oncology Holdings Inc

$1.67

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricALXOREGNWinner
Market Cap$219.79M$79.35BREGN
P/E RatioN/A18.08REGN
EPS (TTM)$N/A$41.51REGN
Revenue Growth-1.0%0.0%REGN
Gross Margin0.0%44.6%REGN

Analyze ALXO

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ALXO or REGN a better investment?

Comparing ALXO and REGN: Alx Oncology Holdings Inc has a market cap of $219.79M while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ALXO and REGN?

ALXO (Alx Oncology Holdings Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ALXO or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ALXO or REGN?

REGN has higher revenue growth at 0.0% vs -1.0% for ALXO.

Which company is more profitable: ALXO or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for ALXO.

Which is the larger company: ALXO or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $219.79M for ALXO.

Should I buy ALXO or REGN in 2026?

Both ALXO and REGN have investment merit. ALXO trades at $1.67 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ALXO and REGN stock?

Key differences: Market Cap ($219.79M vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons